Tokyo Tape
Sign in
← PHC Holdings

Half-year report · HY

6523.TEDINET S100X235
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥173.4bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥361.6bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥173.9bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥10.4bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥9.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥941m2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥18.8bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥7.4bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)−¥559m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥10.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥4.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥692m2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥4.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥525.8bnat 2025-09-30Cons.Assets IFRS
Total assets¥532.5bnat 2025-03-31Cons.Assets IFRS
Total assets¥525.4bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥379.8bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥391.3bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥146.0bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥141.2bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥127.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥139.2bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥146.7bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥141.6bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥127.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥33.3bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥39.6bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥33.0bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥47.0bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥12.1bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥41.9bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥13.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥4.2bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥8.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥17.6bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥39.1bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥20.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-4.422025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥83.132024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥32.522024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-4.422025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥82.582024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥32.422024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio27.9%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.6%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.3%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30¥2.9bn
Reconciling Itemsreconcilingrevenue external2025-04-01 → 2025-09-30¥2.9bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥3.2bn
Diabetes Managementreportable segmentrevenue2025-04-01 → 2025-09-30¥48.7bn
Diabetes Managementreportable segmentrevenue external2025-04-01 → 2025-09-30¥48.7bn
Diabetes Managementreportable segmentsegment profit2025-04-01 → 2025-09-30¥9.3bn
Diagnostics And Life Sciencesreportable segmentrevenue2025-04-01 → 2025-09-30¥59.1bn
Diagnostics And Life Sciencesreportable segmentrevenue external2025-04-01 → 2025-09-30¥59.1bn
Diagnostics And Life Sciencesreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.3bn
Healthcare Solutionsreportable segmentrevenue2025-04-01 → 2025-09-30¥62.7bn
Healthcare Solutionsreportable segmentrevenue external2025-04-01 → 2025-09-30¥62.7bn
Healthcare Solutionsreportable segmentsegment profit2025-04-01 → 2025-09-30¥3.0bn
—segment totalrevenue2025-04-01 → 2025-09-30¥170.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥170.5bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥13.6bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥4.3bn
Diabetes Managementreportable segmentrevenue2024-04-01 → 2024-09-30¥48.3bn
Diabetes Managementreportable segmentrevenue external2024-04-01 → 2024-09-30¥48.3bn
Diabetes Managementreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.4bn
Diagnostics And Life Sciencesreportable segmentrevenue2024-04-01 → 2024-09-30¥62.6bn
Diagnostics And Life Sciencesreportable segmentrevenue external2024-04-01 → 2024-09-30¥62.6bn
Diagnostics And Life Sciencesreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.5bn
Healthcare Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥61.5bn
Healthcare Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥61.5bn
Healthcare Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥172.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥172.3bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥13.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 753
ItemContextValueUnit
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember916000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration－JPY
Total transactions with owners IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1InterimDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Total transactions with owners IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember916000000JPY
Total transactions with owners IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-2148000000JPY
Total transactions with owners IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember－JPY
Total transactions with owners IFRSPrior1InterimDuration-2148000000JPY
Equity IFRSPrior1InterimInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember42654000000JPY
Equity IFRSPrior1InterimInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember271000000JPY
Equity IFRSPrior1InterimInstant_OtherComponentsOfEquityIFRSMember39887000000JPY
Equity IFRSPrior1InterimInstant_EquityAttributableToOwnersOfParentIFRSMember127803000000JPY
Equity IFRSPrior1InterimInstant_NonControllingInterestsIFRSMember-413000000JPY
Equity IFRSPrior1InterimInstant127389000000JPY
Equity IFRSPrior1YearInstant_ShareCapitalIFRSMember48623000000JPY
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember42039000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember2991000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-568000000JPY
Equity IFRSPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior1YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-233000000JPY
Equity IFRSPrior1YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-17000000JPY
Profit loss IFRSInterimDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSInterimDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSInterimDuration_RetainedEarningsIFRSMember-559000000JPY
Profit loss IFRSInterimDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSInterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Other comprehensive income IFRSInterimDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSInterimDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSInterimDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSInterimDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSInterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember211000000JPY
Other comprehensive income IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2418000000JPY
Other comprehensive income IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-0JPY
Comprehensive income IFRSInterimDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSInterimDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSInterimDuration_RetainedEarningsIFRSMember-559000000JPY
Comprehensive income IFRSInterimDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSInterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember211000000JPY
Comprehensive income IFRSInterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2418000000JPY
Comprehensive income IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-0JPY
Issuance of new shares ss IFRSInterimDuration_ShareCapitalIFRSMember158000000JPY
Issuance of new shares ss IFRSInterimDuration_CapitalSurplusIFRSMember173000000JPY
Issuance of new shares ss IFRSInterimDuration_RetainedEarningsIFRSMember－JPY
Issuance of new shares ss IFRSInterimDuration_TreasurySharesIFRSMember－JPY
Issuance of new shares ss IFRSInterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass